Aisling Capital — 2016 Investments
3 investments dated 2016 · listed companies and verified rows first · show all
Earlens makes a hearing aid that vibrates the eardrum directly rather than using speakers to amplify sound, allowing amplification across a broad audible frequency range including higher frequencies for speech understanding.
HardwareHealthtechMedical DevicesMenlo Park, US
Rodney Perkins, M.D.(Director)William M. Facteau(Executive Officer, Director)Bernard Shay(Executive Officer)Phil Lyons(Executive Officer)Brent Edwards(Executive Officer)Greg Koskowich(Executive Officer)
Board seatSteven Elms· per SEC Form D
Co-investorsNew Enterprise Associates (NEA)Windham Capital PartnersLightstone VenturesSightLine Partners
Menlo Park, US
Duke Rohlen(Chief Executive Officer)
BoardCamille Samuels(Director)Anthony Natale(Director)inReed Gaither(Director)Aftab Kherani(Director)Ron Kuppersmith(Director)
Co-investorsAPERTURE Venture PartnersCorrelation VenturesVenrockHealthQuest CapitalVenrock AssociatesWestern Technology Investment
HealthtechLexington, US
Michael Cima, Ph.D.(Director)Rahul Dhanda(Senior Vice President, Corporate Development)John McDonough(Chief Executive Officer)Tom Lowery, Ph.D.(Chief Scientific Officer)Michael Gibbs, Esq.(Vice President and General Counsel)Joanne Spadoro, Ph.D.(Chief Operating Officer)
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.